We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Blocking Phosphatidylcholine Synthesis Lowers Levels of Circulating Lipids in Mouse Hyperlipidemia Model

By LabMedica International staff writers
Posted on 21 Sep 2015
Cardiovascular disease researchers seeking new ways to treat hyperlipidemia found that inhibition of the gene encoding a protein required for biosynthesis of phosphatidylcholine, a major cell membrane component, in a mouse model resulted in decreased levels of lipids (cholesterol, triglyceride, and phospholipid) in circulation. More...


Investigators at SUNY Downstate Medical Center (Brooklyn, NY, USA) genetically engineered a line of C57BL/6J mice to lack the gene for production of the enzyme LPCAT3 (Lysophosphatidylcholine acyltransferase 3), which is involved in the synthesis of the cell membrane lipid phosphatidylcholine (PC).

The investigators reported in the July 28, 2015, online edition of the journal Gastroenterology that knock-out (KO) mice lacking the LPCAT3 gene survived only three weeks after birth. Oil Red O staining showed that the controls, but not LPCAT3 KO mice, accumulated lipids in the small intestine.

Oral administration of PC and olive oil allowed the LPCAT3 KO mice to survive, with the same body weights as controls, but the KO mice had shorter and wider small-intestinal villi and longer and bigger small intestines. These modifications were associated with reduced intestinal uptake of lipid by the small intestine and reduced plasma levels of cholesterol, phospholipid, and triglyceride.

"Hyperlipidemia, or high levels of lipids, is a common disease and contributes significantly to cardiac related morbidity and mortality," said senior author Dr. Xian-Cheng Jiang, professor of cell biology at SUNY Downstate Medical Center. "Statin drug trials have provided the major evidence for the benefits of a therapy that lowers low density lipoprotein (LDL), the so called "bad cholesterol", and statin therapy is now the mainstay of clinical management of cardiovascular disease. However, there are many instances in which patients do not respond to or cannot tolerate statins. Our study is intended to provide a novel approach to reduce the "bad" lipids in the blood. Although the study was conducted in a mouse model, the outcomes may be applicable to humans."

Related Links:

SUNY Downstate Medical Center



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Serological Pipet Controller
PIPETBOY GENIUS
New
Plasmodium Test
Plasmodium DNA Real Time PCR Kit
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: Cord blood proteomics can identify biomarkers of early-onset neonatal sepsis (Photo courtesy of JCI Insight (2025). DOI: 10.1172/jci.insight.193826)

Umbilical Cord Blood Test Can Detect Early Sepsis in Preterm Infants

Diagnosing early onset sepsis (EOS) in preterm infants is particularly difficult due to the lack of specific clinical signs, leading to widespread use of antibiotics while awaiting culture results.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.